Assessment Drug Reports

This report was prepared by the Trimbos Institute, under the Central Asia Drug Action Programme (CADAP – Phase 6) Policy Component (C1), benefitting from valuable contributions from European and Central Asian drug policy experts.

Trimbos Institute is grateful to all participating competent agencies which shared their data and information with the team, in particular all involved national authorities and other stakeholders in the Central Asian Countries responsible for drug policies.

Trimbos Insitute is thankful to the Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH in its function as CADAP project leader for supporting the preparation and publication of this report that benefited from financial contributions from the European Union and Germany.